- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 15, 2024 | 281.94M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $23.49K |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $2.69M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $2.41M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $3.67M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $3.48M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $1.9M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $656.16K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $3.89M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $4.28M |
| Total Assets restated | Q1 2024 · Mar 31, 2023 | $5.83M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 257.13M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$1.1M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $2.17M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $314.45K |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.01 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | $0.01 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $1.1M |
| Net Income | Q1 2024 · Mar 31, 2023 | $1.45M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$1.06M |